Blood Culture Test Market Size, Share and Trends Analysis Report By Product, By Application, By End Use, By Region And Segment Forecasts 2022 – 2031

Kenneth Research has recently added a report titled  Blood Culture Test Market in its storehouse of market research reports. The report provides a detailed insight into the market scenario on the basis of the market size and volume for the forecast period, i.e., 2022-2031.

U S Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analysis and U.S. Census Bureau mention the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) average exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilst imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Blood Culture Test Market products.

“Final Report will add the analysis of the impact of COVID-19 on this industry.”

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10346965

Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018.

Global Blood Culture Test Market is valued approximately at USD 4.03 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 8% over the forecast period 2020-2027. Blood cultures are tests that are carried out to diagnose and determine the source of an infection in the blood. Bloodstream infections are most often caused by bacteria, but they may also be caused by yeast or other fungi or a virus. The driving factors of the market could be attributed to increase in product approvals of Consumables & Instrument and launches, rise in aging population prevalence of infectious diseases, blood stream infections, and sepsis. According to the World Health Organization (WHO), in 2019 around 250,000 cases of BSIs occur in the U.S. annually and among them, about 80,000 patients suffer from catheter-related BSIs in ICUs. As a result, there is a strong demand for innovative products for the diagnosis of bacterial, fungal, and mycobacterial infections by hospitals and clinical diagnostics laboratories.

Many healthcare businesses have increased R&D activities to develop innovative products such as materials, consumables, and software. Investment in R&D for the production of a novel product is a key strategy for suppliers to support their companies’ long-term growth. For example, in 2017 USD 1,433 million was invested by Becton, Dickinson and Company, a prominent provider of blood culture testing products. However, market growth could be hampered by stringent government regulations for the production and manufacturing of diagnostic products, including products for blood culture tests. Until regulatory approval, diagnostic products, such as instruments, kits, reagents, media, and assays, undergo comprehensive clinical trials, leading to a major surge in manufacturers’ costs and thus delay in the launch of the product. Therefore, this may act as a restraint and affect the market growth.

The regional analysis of global Blood Culture Test is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to rising awareness about early disease diagnosis, increasing adoption of advanced technologies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027, owing to high incidence of sepsis and government initiatives thus, it would create lucrative growth prospects for the Blood Culture Test market across Asia-Pacific region.

Major market player included in this report are:

Becton, Dickinson and Company
bioMérieux SA
Thermo Fisher Scientific, Inc.
Cepheid, Inc.
Nanosphere, Inc.
Roche Diagnostics
Beckman Coulter
Bruker Corporation
T2 Biosystems

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

Get a Sample Copy of this Report with Graphs and Charts: https://www.kennethresearch.com/sample-request-10346965

The detailed segments and sub-segment of the market are explained below:
by Application:
by Product:
by Method:
by Technology:
Polymerase chain reaction (PCR)
by End User:
Hospital Laboratories
Reference Laboratories

By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Blood Culture Test Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Request For Full Report: https://www.kennethresearch.com/sample-request-10346965

About Kenneth Research

Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defence, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.

Contact Us

Kenneth Research

Email : Sales@kennethresearch.com

Phone: +1 313 462 0609

Leave a Reply